SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001640455-21-000149
Filing Date
2021-11-04
Accepted
2021-11-04 16:17:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 424B5 jnceatm11042021424b5.htm 424B5 448926
  Complete submission text file 0001640455-21-000149.txt   449886
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-255760 | Film No.: 211380209
SIC: 2836 Biological Products, (No Diagnostic Substances)